OrganiGram Holdings Inc. (OGI)
NASDAQ: OGI · IEX Real-Time Price · USD
1.650
+0.030 (1.85%)
At close: Jul 19, 2024, 4:00 PM
1.700
+0.050 (3.03%)
Pre-market: Jul 22, 2024, 6:08 AM EDT
OrganiGram Holdings Market Cap
OrganiGram Holdings has a market cap or net worth of $170.56 million as of July 22, 2024. Its market cap has increased by 38.89% in one year.
Market Cap
170.56M
Enterprise Value
117.83M
1-Year Change
38.89%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since May 21, 2019, OrganiGram Holdings's market cap has decreased from $1.01B to $170.56M, a decrease of -83.19%. That is a compound annual growth rate of -29.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 155.90M | 46.66% |
| Dec 29, 2023 | 106.30M | -57.67% |
| Dec 30, 2022 | 251.10M | -51.98% |
| Dec 31, 2021 | 522.90M | 151.76% |
| Dec 31, 2020 | 207.70M | -45.73% |
| Dec 31, 2019 | 382.70M | -62.29% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 173.22M |
| Atossa Therapeutics | 171.03M |
| Rani Therapeutics Holdings | 169.91M |
| Rigel Pharmaceuticals | 168.91M |
| INmune Bio | 168.74M |
| Compugen | 167.42M |
| Skye Bioscience | 167.28M |
| Repare Therapeutics | 167.23M |